Literature DB >> 12917052

The DAVID trial and its implications: where do we go from here?

Brian Olshansky.   

Abstract

Year:  2003        PMID： 12917052     DOI： 10.1007/s11886-003-0094-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  10 in total

1.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.

Authors:  S J Connolly; C R Kerr; M Gent; R S Roberts; S Yusuf; A M Gillis; M H Sami; M Talajic; A S Tang; G J Klein; C Lau; D M Newman
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

2.  Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy.

Authors:  M Hochleitner; H Hörtnagl; C K Ng; H Hörtnagl; F Gschnitzer; W Zechmann
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

3.  Comparison of right ventricular outflow tract and apical lead permanent pacing on cardiac output.

Authors:  M C Giudici; G A Thornburg; D L Buck; E P Coyne; M C Walton; D L Paul; J Sutton
Journal:  Am J Cardiol       Date:  1997-01-15       Impact factor: 2.778

4.  Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers.

Authors:  L A Saxon; W G Stevenson; H R Middlekauff; L W Stevenson
Journal:  Am Heart J       Date:  1993-05       Impact factor: 4.749

5.  Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease.

Authors:  A J Moss; Y Fadl; W Zareba; D S Cannom; W J Hall
Journal:  Am J Cardiol       Date:  2001-09-01       Impact factor: 2.778

6.  The acute hemodynamic effects of right ventricular septal pacing in patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Authors:  M R Gold; S R Shorofsky; M D Metcalf; Z Feliciano; M L Fisher; S S Gottlieb
Journal:  Am J Cardiol       Date:  1997-03-01       Impact factor: 2.778

7.  Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators.

Authors:  G A Lamas; E J Orav; B S Stambler; K A Ellenbogen; E B Sgarbossa; S K Huang; R A Marinchak; N A Estes; G F Mitchell; E H Lieberman; C M Mangione; L Goldman
Journal:  N Engl J Med       Date:  1998-04-16       Impact factor: 91.245

8.  The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients.

Authors:  G A Lamas; K Lee; M Sweeney; A Leon; R Yee; K Ellenbogen; S Greer; D Wilber; R Silverman; R Marinchak; R Bernstein; R S Mittleman; E H Lieberman; C Sullivan; L Zorn; G Flaker; E Schron; E J Orav; L Goldman
Journal:  Am Heart J       Date:  2000-10       Impact factor: 4.749

9.  Influence of right ventricular stimulation site on left ventricular function in atrial synchronous ventricular pacing.

Authors:  B Schwaab; G Fröhlig; C Alexander; M Kindermann; N Hellwig; H Schwerdt; C M Kirsch; H Schieffer
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

10.  QRS duration and mortality in patients with congestive heart failure.

Authors:  Stephen Iuliano; Susan G Fisher; Pamela E Karasik; Ross D Fletcher; Steven N Singh
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.